Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Co-Diagnostics, Inc. (CODX) had Free Cash Flow per Share of $-0.53 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.16M |
|
$-7.73M |
|
$0.03M |
|
$0.13M |
|
$8.22M |
|
$-8.06M |
|
$0.34M |
|
$-7.72M |
|
$-8.06M |
|
$-7.73M |
|
$-7.73M |
|
$-7.73M |
|
$-8.07M |
|
$-8.06M |
|
$-7.77M |
|
33.11M |
|
33.11M |
|
$-0.23 |
|
$-0.23 |
|
| Balance Sheet Financials | |
$15.31M |
|
$2.67M |
|
$31.16M |
|
$46.47M |
|
$3.71M |
|
-- |
|
$1.62M |
|
$5.33M |
|
$41.14M |
|
$15.04M |
|
$41.14M |
|
36.18M |
|
| Cash Flow Statement Financials | |
$-17.03M |
|
$24.43M |
|
$0.78M |
|
$2.94M |
|
$11.12M |
|
$8.18M |
|
$1.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
80.29% |
|
-4946.15% |
|
-4946.15% |
|
-- |
|
-4737.46% |
|
-4745.02% |
|
$-17.53M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.03 |
|
0.77 |
|
116.55 |
|
-18.79% |
|
-51.41% |
|
-16.64% |
|
-18.79% |
|
$1.14 |
|
|
Free Cash Flow per Share |
$-0.53 |
$-0.51 |
|